Norbert Brüggemann1,2, Aloysius Domingo1, Dirk Rasche3, Christian K E Moll4, Raymond L Rosales5, Roland Dominic G Jamora6,7, Henrike Hanssen1,2, Alexander Münchau1, Julia Graf1,2, Anne Weissbach1, Vera Tadic1,2, Cid C Diesta8, Jens Volkmann9, Andrea Kühn10, Thomas F Münte2, Volker Tronnier3, Christine Klein1. 1. Institute of Neurogenetics, University of Lübeck, Lübeck, Germany. 2. Department of Neurology, University Hospital Lübeck, Lübeck, Germany. 3. Department of Neurosurgery, University Hospital Lübeck, Lübeck, Germany. 4. Department of Neurophysiology and Pathophysiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. 5. Department of Neurology and Psychiatry, University of Santo Tomas Hospital, Manila, Philippines. 6. Department of Neurosciences, College of Medicine-Philippine General Hospital, University of the Philippines Manila, Manila, Philippines. 7. Institute for Neurosciences, St. Luke's Medical Center, Quezon City and Global City, Philippines. 8. Asian Hospital and Medical Center, Muntinlupa City, Philippines. 9. Department of Neurology, University Hospital Würzburg, Würzburg, Germany. 10. Department of Neurology, Charité- Universitätsmedizin Berlin, Berlin, Germany.
Abstract
Importance: Anecdotal evidence suggests that deep brain stimulation (DBS) of the internal globus pallidus (GPi) is effective in ameliorating dystonia in X-linked dystonia parkinsonism (XDP), a disease that is usually refractive to medical therapy. Objective: To determine the efficacy of GPi-DBS in a cohort of patients with XDP in a prospective study and identify predictors of postoperative outcomes. Design, Setting, and Participants: This observational prospective cohort study enrolled patients in February 2013 and was completed in December 2014. The patients were followed up for up to 46 months. Patients from the Philippines were treated in a single center in Lübeck, Germany and followed up in the Philippines. Sixteen men with XDP (mean [SD] age, 40.9 [7.3] years; disease duration, 1-6 years) from the Philippines with predominant dystonia were selected. Exposures: All patients underwent bilateral GPi-DBS in Lübeck, Germany. Main Outcomes and Measures: Clinical assessment included the motor parts of the Burke-Fahn-Marsden scale (BFMDRS-M) and the Unified Parkinson's Disease Rating Scale (UPDRS-III). T1-based basal ganglia volumetry was performed and correlated with postoperative outcomes. Results: The study participants included 16 Filipino men (mean age, 40.9 years). Masked video ratings revealed significant improvements of dystonia severity 1 week (-55%; range, -94% to 59%; P < .01) and 6 months (-59%; range, -100% to 22%; P < .001) after surgery. The UDPRS-III score also improved, albeit to a lesser extent (-19%; range, -54% to 95%; and -27%; range, -70% to 124%; respectively). Unmasked long-term follow-up confirmed the continued efficacy of GPi-DBS up to 46 months after surgery. Important secondary end points improved, including activities of daily living, pain severity, weight, and quality of life. Caudate atrophy was a predictor of a less beneficial outcome (r = 0.817, P = .004). Conclusions and Relevance: Internal globus pallidus DBS had a positive association in XDP with predominant dystonia (the primary end point) and contributed to an improved quality of life (the secondary end point). The response to DBS occurred within 1 week. Given the inverse correlation of postoperative benefit and caudate atrophy, GPi-DBS should be considered early during the disease course. Close international collaboration, training, and funding from multiple sources enabled the sustainable follow-up of patients with XDP in the Philippines.
Importance: Anecdotal evidence suggests that deep brain stimulation (DBS) of the internal globus pallidus (GPi) is effective in ameliorating dystonia in X-linked dystonia parkinsonism (XDP), a disease that is usually refractive to medical therapy. Objective: To determine the efficacy of GPi-DBS in a cohort of patients with XDP in a prospective study and identify predictors of postoperative outcomes. Design, Setting, and Participants: This observational prospective cohort study enrolled patients in February 2013 and was completed in December 2014. The patients were followed up for up to 46 months. Patients from the Philippines were treated in a single center in Lübeck, Germany and followed up in the Philippines. Sixteen men with XDP (mean [SD] age, 40.9 [7.3] years; disease duration, 1-6 years) from the Philippines with predominant dystonia were selected. Exposures: All patients underwent bilateral GPi-DBS in Lübeck, Germany. Main Outcomes and Measures: Clinical assessment included the motor parts of the Burke-Fahn-Marsden scale (BFMDRS-M) and the Unified Parkinson's Disease Rating Scale (UPDRS-III). T1-based basal ganglia volumetry was performed and correlated with postoperative outcomes. Results: The study participants included 16 Filipino men (mean age, 40.9 years). Masked video ratings revealed significant improvements of dystonia severity 1 week (-55%; range, -94% to 59%; P < .01) and 6 months (-59%; range, -100% to 22%; P < .001) after surgery. The UDPRS-III score also improved, albeit to a lesser extent (-19%; range, -54% to 95%; and -27%; range, -70% to 124%; respectively). Unmasked long-term follow-up confirmed the continued efficacy of GPi-DBS up to 46 months after surgery. Important secondary end points improved, including activities of daily living, pain severity, weight, and quality of life. Caudate atrophy was a predictor of a less beneficial outcome (r = 0.817, P = .004). Conclusions and Relevance: Internal globus pallidus DBS had a positive association in XDP with predominant dystonia (the primary end point) and contributed to an improved quality of life (the secondary end point). The response to DBS occurred within 1 week. Given the inverse correlation of postoperative benefit and caudate atrophy, GPi-DBS should be considered early during the disease course. Close international collaboration, training, and funding from multiple sources enabled the sustainable follow-up of patients with XDP in the Philippines.
Authors: Roland Dominic G Jamora; Cid Czarina E Diesta; Paul Matthew D Pasco; Lillian V Lee Journal: Int J Neurosci Date: 2011-01-19 Impact factor: 2.292
Authors: Norbert Brüggemann; Marcus Heldmann; Christine Klein; Aloysius Domingo; Dirk Rasche; Volker Tronnier; Raymond L Rosales; Roland Dominic G Jamora; Lillian V Lee; Thomas F Münte Journal: Parkinsonism Relat Disord Date: 2016-07-26 Impact factor: 4.891
Authors: Ioannis U Isaias; Jens Volkmann; Andreas Kupsch; Jean-Marc Burgunder; Jill L Ostrem; Ron L Alterman; Hubertus Maximilian Mehdorn; Thomas Schönecker; Joachim K Krauss; Philip Starr; Rene Reese; Andrea A Kühn; W M Michael Schüpbach; Michele Tagliati Journal: J Neurol Date: 2011-03-02 Impact factor: 4.849
Authors: Andreas Kupsch; Reiner Benecke; Jörg Müller; Thomas Trottenberg; Gerd-Helge Schneider; Werner Poewe; Wilhelm Eisner; Alexander Wolters; Jan-Uwe Müller; Günther Deuschl; Marcus O Pinsker; Inger Marie Skogseid; Geir Ketil Roeste; Juliane Vollmer-Haase; Angela Brentrup; Martin Krause; Volker Tronnier; Alfons Schnitzler; Jürgen Voges; Guido Nikkhah; Jan Vesper; Markus Naumann; Jens Volkmann Journal: N Engl J Med Date: 2006-11-09 Impact factor: 91.245
Authors: Tatsiana Aneichyk; William T Hendriks; Rachita Yadav; David Shin; Dadi Gao; Christine A Vaine; Ryan L Collins; Aloysius Domingo; Benjamin Currall; Alexei Stortchevoi; Trisha Multhaupt-Buell; Ellen B Penney; Lilian Cruz; Jyotsna Dhakal; Harrison Brand; Carrie Hanscom; Caroline Antolik; Marisela Dy; Ashok Ragavendran; Jason Underwood; Stuart Cantsilieris; Katherine M Munson; Evan E Eichler; Patrick Acuña; Criscely Go; R Dominic G Jamora; Raymond L Rosales; Deanna M Church; Stephen R Williams; Sarah Garcia; Christine Klein; Ulrich Müller; Kirk C Wilhelmsen; H T Marc Timmers; Yechiam Sapir; Brian J Wainger; Daniel Henderson; Naoto Ito; Neil Weisenfeld; David Jaffe; Nutan Sharma; Xandra O Breakefield; Laurie J Ozelius; D Cristopher Bragg; Michael E Talkowski Journal: Cell Date: 2018-02-22 Impact factor: 66.850
Authors: Paul Matthew D Pasco; Roland Dominic G Jamora; Raymond L Rosales; Cid Czarina E Diesta; Arlene R Ng; Rosalia A Teleg; Criscely L Go; Lillian Lee; Hubert H Fernandez Journal: NPJ Parkinsons Dis Date: 2017-07-25
Authors: Roland Dominic G Jamora; Cezar Thomas R Suratos; Jesi Ellen C Bautista; Gail Melissa I Ramiro; Ana Westenberger; Christine Klein; Lourdes K Ledesma Journal: J Neural Transm (Vienna) Date: 2021-02-27 Impact factor: 3.575
Authors: Lindsey N Campion; Alan Mejia Maza; Rachita Yadav; Ellen B Penney; Micaela G Murcar; Kevin Correia; Tammy Gillis; Cara Fernandez-Cerado; M Salvie Velasco-Andrada; G Paul Legarda; Niecy G Ganza-Bautista; J Benedict B Lagarde; Patrick J Acuña; Trisha Multhaupt-Buell; Gabrielle Aldykiewicz; Melanie L Supnet; Jan K De Guzman; Criscely Go; Nutan Sharma; Edwin L Munoz; Mark C Ang; Cid Czarina E Diesta; D Cristopher Bragg; Laurie J Ozelius; Vanessa C Wheeler Journal: Acta Neuropathol Commun Date: 2022-04-08 Impact factor: 7.801